Cohen Investment Advisors LLC Biogen Inc. Transaction History

Cohen Investment Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 28, 2021	SELL	$282.99 - $369.05 $1.61 Million - $2.09 Million	-5,674 Closed	0 $0
Q2 2021 Aug 09, 2021	SELL	$259.0 - $414.71 $104,377 - $167,128	-403 Reduced 6.63%	5,674 $1.97 Million
Q1 2021 Aug 05, 2021	SELL	$242.95 - $284.63 $36.9 Million - $43.2 Million	-151,732 Reduced 96.15%	6,077 $1.64 Million
Q1 2021 May 12, 2021	BUY	$242.95 - $284.63 $37 Million - $43.4 Million	152,426 Added 2831.62%	157,809 $1.42 Million
Q4 2020 Feb 11, 2021	BUY	$236.26 - $355.63 $1.27 Million - $1.91 Million	5,383 New	5,383 $1.32 Million

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Cohen Investment Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Cohen Investment Advisors LLC with notifications on news.